Evidence map›Paper›PMID 39065049›Full record

ArticleMicroorganisms2024

Screening of the Biocontrol Efficacy of Potent

Ranjna Kumari, Vipul Kumar, Ananta Prasad Arukha, Muhammad Fazle Rabbee, Fuad Ameen, Bhupendra Koul

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. In-vitro evaluation of selected nativeFrontiers in microbiology · 2026
    Article
  7. Mechanisms of action and biocontrol potential ofFrontiers in fungal biology · 2026
    Review
  8. IndigenousFrontiers in microbiology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Protease and chitinase activity ofFrontiers in microbiology · 2025
    Article
  15. Article
  16. Synergistic effects ofFrontiers in microbiology · 2025
    Article
  17. Review
  18. Co-inoculation ofFrontiers in plant science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ranjna KumariDepartment of Botany, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0001-9899-0660
Vipul KumarDepartment of Plant Pathology, School of Agriculture, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0002-5216-7967
Ananta Prasad ArukhaDepartment of Nephrology and Hypertension, Mayo Medical Sciences, Rochester, MN 55902, USA.ORCID 0000-0003-0382-6054
Muhammad Fazle RabbeeDepartment of Biotechnology, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Fuad AmeenDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-5185-022X
Bhupendra KoulDepartment of Botany, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0002-8409-3624

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chickpeas contribute to half of the pulses produced in India and are an excellent source of protein, fibers, carbohydrates, minerals, and vitamins. However, the combination of the wilt and root rot diseases drastically lowers its yield. The use of antagonist microbes that restrict the growth of other phytopathogens is an ecofriendly approach to combat the serious threats raised by the plant pathogens.

Indexed as

BiocontrolFusarium oxysporumPathogensSclerotium rolfsiiTrichoderma

Identifiers

PMID39065049
PMCPMC11278996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.